Cargando…

Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis

Photodynamic therapy (PDT) has emerged as a promising tumor treatment method via light-triggered generation of reactive oxygen species (ROS) to kill tumor cells. However, the efficacy of PDT is usually restricted by several biological limitations, including hypoxia, excess glutathione (GSH) neutrali...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xiaoxiong, Chen, Min, Zhang, Yuchen, Li, Liang, Peng, Ying, Zhou, Wenhu, Li, Junyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479271/
https://www.ncbi.nlm.nih.gov/pubmed/36109814
http://dx.doi.org/10.1186/s12951-022-01617-0
_version_ 1784790751527305216
author Xiao, Xiaoxiong
Chen, Min
Zhang, Yuchen
Li, Liang
Peng, Ying
Zhou, Wenhu
Li, Junyu
author_facet Xiao, Xiaoxiong
Chen, Min
Zhang, Yuchen
Li, Liang
Peng, Ying
Zhou, Wenhu
Li, Junyu
author_sort Xiao, Xiaoxiong
collection PubMed
description Photodynamic therapy (PDT) has emerged as a promising tumor treatment method via light-triggered generation of reactive oxygen species (ROS) to kill tumor cells. However, the efficacy of PDT is usually restricted by several biological limitations, including hypoxia, excess glutathione (GSH) neutralization, as well as tumor resistance. To tackle these issues, herein we developed a new kind of DNA nanozyme to realize enhanced PDT and synergistic tumor ferroptosis. The DNA nanozyme was constructed via rolling circle amplification, which contained repeat AS1411 G quadruplex (G4) units to form multiple G4/hemin DNAzymes with catalase-mimic activity. Both hemin, an iron-containing porphyrin cofactor, and chlorine e6 (Ce6), a photosensitizer, were facilely inserted into G4 structure with high efficiency, achieving in-situ catalytic oxygenation and photodynamic ROS production. Compared to other self-oxygen-supplying tools, such DNA nanozyme is advantageous for high biological stability and compatibility. Moreover, the nanostructure could achieve tumor cells targeting internalization and intranuclear transport of Ce6 by virtue of specific nucleolin binding of AS1411. The nanozyme could catalyze the decomposition of intracellular H(2)O(2) into oxygen for hypoxia relief as evidenced by the suppression of hypoxia-inducible factor-1α (HIF-1α), and moreover, GSH depletion and cell ferroptosis were also achieved for synergistic tumor therapy. Upon intravenous injection, the nanostructure could effectively accumulate into tumor, and impose multi-modal tumor therapy with excellent biocompatibility. Therefore, by integrating the capabilities of O(2) generation and GSH depletion, such DNA nanozyme is a promising nanoplatform for tumor PDT/ferroptosis combination therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01617-0.
format Online
Article
Text
id pubmed-9479271
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94792712022-09-17 Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis Xiao, Xiaoxiong Chen, Min Zhang, Yuchen Li, Liang Peng, Ying Zhou, Wenhu Li, Junyu J Nanobiotechnology Research Photodynamic therapy (PDT) has emerged as a promising tumor treatment method via light-triggered generation of reactive oxygen species (ROS) to kill tumor cells. However, the efficacy of PDT is usually restricted by several biological limitations, including hypoxia, excess glutathione (GSH) neutralization, as well as tumor resistance. To tackle these issues, herein we developed a new kind of DNA nanozyme to realize enhanced PDT and synergistic tumor ferroptosis. The DNA nanozyme was constructed via rolling circle amplification, which contained repeat AS1411 G quadruplex (G4) units to form multiple G4/hemin DNAzymes with catalase-mimic activity. Both hemin, an iron-containing porphyrin cofactor, and chlorine e6 (Ce6), a photosensitizer, were facilely inserted into G4 structure with high efficiency, achieving in-situ catalytic oxygenation and photodynamic ROS production. Compared to other self-oxygen-supplying tools, such DNA nanozyme is advantageous for high biological stability and compatibility. Moreover, the nanostructure could achieve tumor cells targeting internalization and intranuclear transport of Ce6 by virtue of specific nucleolin binding of AS1411. The nanozyme could catalyze the decomposition of intracellular H(2)O(2) into oxygen for hypoxia relief as evidenced by the suppression of hypoxia-inducible factor-1α (HIF-1α), and moreover, GSH depletion and cell ferroptosis were also achieved for synergistic tumor therapy. Upon intravenous injection, the nanostructure could effectively accumulate into tumor, and impose multi-modal tumor therapy with excellent biocompatibility. Therefore, by integrating the capabilities of O(2) generation and GSH depletion, such DNA nanozyme is a promising nanoplatform for tumor PDT/ferroptosis combination therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01617-0. BioMed Central 2022-09-15 /pmc/articles/PMC9479271/ /pubmed/36109814 http://dx.doi.org/10.1186/s12951-022-01617-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xiao, Xiaoxiong
Chen, Min
Zhang, Yuchen
Li, Liang
Peng, Ying
Zhou, Wenhu
Li, Junyu
Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
title Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
title_full Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
title_fullStr Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
title_full_unstemmed Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
title_short Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
title_sort hemin-incorporating dna nanozyme enabling catalytic oxygenation and gsh depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479271/
https://www.ncbi.nlm.nih.gov/pubmed/36109814
http://dx.doi.org/10.1186/s12951-022-01617-0
work_keys_str_mv AT xiaoxiaoxiong heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis
AT chenmin heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis
AT zhangyuchen heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis
AT liliang heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis
AT pengying heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis
AT zhouwenhu heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis
AT lijunyu heminincorporatingdnananozymeenablingcatalyticoxygenationandgshdepletionforenhancedphotodynamictherapyandsynergistictumorferroptosis